A phase I trial of docetaxel and 5-day continuous infusion of 5-fluorouracil in patients with advanced or recurrent breast cancer.
Ando M, Watanabe T, Sasaki Y, Ying DF, Omuro Y, Katsumata N, Narabayashi M, Tokue Y, Fujii H, Igarashi T, Wakita H, Ohtsu T, Itoh K, Adachi I, Taguchi T.
Ando M, et al. Among authors: katsumata n.
Br J Cancer. 1998 Jun;77(11):1937-43. doi: 10.1038/bjc.1998.321.
Br J Cancer. 1998.
PMID: 9667671
Free PMC article.
Clinical Trial.